Recent Development of Non-Peptide GnRH Antagonists.

about

Recent Development of Non-Peptide GnRH Antagonists.

Item

http://www.wikidata.org/entity/Q47323557

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Recent Development of Non-Peptide GnRH Antagonists.

@en

Recent Development of Non-Peptide GnRH Antagonists.

@nl

type

Item

label

Recent Development of Non-Peptide GnRH Antagonists.

@en

Recent Development of Non-Peptide GnRH Antagonists.

@nl

prefLabel

Recent Development of Non-Peptide GnRH Antagonists.

@en

Recent Development of Non-Peptide GnRH Antagonists.

@nl

P1476

Recent Development of Non-Peptide GnRH Antagonists

@en

P2093

Anita Kaass

http://www.w3.org/2001/XMLSchema#string

Feng-Ling Tukun

http://www.w3.org/2001/XMLSchema#string

Ira Haraldsen

http://www.w3.org/2001/XMLSchema#string

Jo Klaveness

http://www.w3.org/2001/XMLSchema#string

Patrick J Riss

http://www.w3.org/2001/XMLSchema#string

P2860

Gonadotropin-releasing hormone receptors

The discovery of novel small molecule non-peptide gonadotropin releasing hormone (GnRH) receptor antagonists.

Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats.

Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position: a highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor.

Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study.

Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.

Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix.

New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin.

Synthesis and in vitro evaluation of small-molecule [18F] labeled gonadotropin-releasing hormone (GnRH) receptor antagonists as potential PET imaging agents for GnRH receptor expression.

Rapid Anti-Inflammatory Effects of Gonadotropin-Releasing Hormone Antagonism in Rheumatoid Arthritis Patients with High Gonadotropin Levels in the AGRA Trial

P31

scholarly article

review article

P356

10.3390/MOLECULES22122188

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dag Erlend Olberg

P577

2017-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29232843

http://www.w3.org/2001/XMLSchema#string

P932

6149776

http://www.w3.org/2001/XMLSchema#string